연구동향 분석

원저 : 건선 환자에서 경구 Cyclosporine 치료 후 재발인자에 대한 연구

문성훈 ( Seong Hun Moon ) 김정은 ( Jeong Eun Kim ) 고주연 ( Joo Yeon Ko ) 노영석 ( Young Suck Ro ) 2015년

논문상세정보
인용/피인용
' 원저 : 건선 환자에서 경구 Cyclosporine 치료 후 재발인자에 대한 연구' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • cyclosporine
  • psoriasis
  • recurrence
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
261 0

0.0%

' 원저 : 건선 환자에서 경구 Cyclosporine 치료 후 재발인자에 대한 연구' 의 참고문헌

  • 중등증 내지 중증 판상건선에서 Methotrexate와Cyclosporine A의 효능 및 부작용에 대한 비교
    김상엽 대한피부과학회지 52 (9) : 615 ~ 621 [2014]
  • 경증 및 중등증 건선환자에서의 사이클로스포린 치료의 효능 및 안전성에 대한 후향적 연구
    이광준 대한피부과학회지 43 (12) : 1619 ~ 1625 [2005]
  • Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks
    Naldi L Br J Dermatol 152 : 597 ~ 615 [2005]
  • The use of cyclosporine in dermatology: part I
    Amor KT J Am Acad Dermatol 63 : 925 ~ 946 [2010]
  • The use of ciclosporin in psoriasis: a clinical review
    Ho VC Br J Dermatol 150 (suppl 67) : 1 ~ 10 [2004]
  • The Salford Psoriasis Index: an holistic measure of psoriasis severity
    Kirby B Br J Dermatol 142 : 728 ~ 732 [2000]
  • Prevalence and treatment of psoriasis in the United Kingdom: a population-based study
    Gelfand JM Arch Dermatol 141 : 1537 ~ 1541 [2005]
  • Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis
    Heydendael VM N Engl J Med 349 : 658 ~ 665 [2003]
  • Maintenance treatment of psoriasis with cyclosporine A: comparison between con tinuous and weekend therapy
    Fernandes IC J Am Acad Dermatol 68 : 341 ~ 342 [2013]
  • Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement
    Mahrle G J Am Acad Dermatol 32 : 78 ~ 88 [1995]
  • Long-term safety of cyclosporine in the treatment of psoriasis
    Grossman RM Arch Dermatol 132 : 623 ~ 629 [1996]
  • Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis:a 2-year cohort study
    Ho VC J Am Acad Dermatol 44 : 643 ~ 651 [2001]
  • High Sensitivity C-reactive Protein을 이용하여 분석한 전신 염증과 단기간 저용량 Cyclosporine의 건선 치료효과의 상관관계
    정택조 대한피부과학회지 48 (3) : 171 ~ 178 [2010]
  • Fitzpatrick’s dermatology in General Medicine. 8th ed : 197 ~ 231
  • Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
    Leonardi CL Lancet 371 : 1665 ~ 1674 [2008]
  • Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, doubleblind, placebo-controlled trial (PHOENIX 2)
    Papp KA Lancet 371 : 1675 ~ 1684 [2008]
  • Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
    Papp KA Br J Dermatol 168 : 412 ~ 421 [2013]
  • Cyclosporine consensus conference: with emphasis on the treatment of psoriasis
  • Cyclosporine as maintenance therapy in patients with severe psoriasis
    Shupack J J Am Acad Dermatol 36 : 423 ~ 432 [1997]
  • Cyclosporin A for psoriasis
    Mueller W N Engl J Med 301 : 555 ~ [1979]
  • Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine
    Opmeer BC Arch Dermatol 140 : 685 ~ 690 [2004]
  • Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis
    Griffiths CE N Engl J Med 362 : 118 ~ 128 [2010]
  • Calcipotriol improves the efficacy of cyclosporine in the treatment of psoriasis vulgaris
    Kokelj F J Eur Acad Dermatol Venereol 10 : 143 ~ 146 [1998]
  • Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis
    Papp KA N Engl J Med 366 : 1181 ~ 1189 [2012]
  • Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis
    Leonardi C N Engl J Med 366 : 1190 ~ 1199 [2012]